In February 2026, Recursion Pharmaceuticals reported fourth-quarter 2025 revenue of US$35.54 million, sharply higher than a ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the 11 most popular AI penny stocks to buy now. On February 25, ...

Recursion Pharmaceuticals, Inc ( (RXRX)) has held its Q4 earnings call. Read on for the main highlights of the call.

MATLAB courses explain programming, simulations, and data analysis used in engineering and research work.Online platforms and ...

Elon Musk’s xAI has brought on board Indian-origin developer Aman Gottumukkala, the founder of Firebender, as part of its ...

So, you want to get better at those tricky LeetCode Python problems, huh? It’s a common goal, especially if you’re aiming for tech jobs. Many people try to just grind through tons of problems, but ...

Gottumukkala is best known as the co-founder of Firebender, an AI coding assistant designed for Android developers.

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

After scaling his three-person startup Firebender to millions in revenue, Gottumukkala moves to Elon Musk’s artificial ...

Indian-origin software engineer Aman Gottumukkala, founder of AI coding startup Firebender, has joined Elon Musk’s artificial intelligence company xAI. Musk welcomed him to the team after Gottumukkala ...

array(1) { [0]=> object(AdvItems)#303 (17) { ["image"]=> NULL ["delete_image"]=> NULL ["publish_start_int"]=> string(10) "1772305246" ["publish_end_int"]=> string(10 ...